Legislation and regulation

PR1: Number of drug outlets inspected, out of total number of drug outlets in the country

PR2: Number of drug outlets in violation, out of total number of drug outlets inspected

PR3: Number of sanctions and administrative measures implemented, out of total number of violations identified

PR4: Number of samples routinely collected, out of total number of planned collected samples

PR5: Number of samples tested, out of total number of samples collected

PR6: Number of advertisements in violation of regulations on the ethical promotion of drugs, out of total number of advertisements monitored

PR7: Number of sanctions implemented for advertisements in violation of regulations, out of total number of violations identified

Essential drug selection and drug registration

PR8: Value of drugs from the national essential drugs list (EDL) procured in the public sector, out of total value of drugs procured in the same sector

PR9: Number of drugs from the national essential drugs list (EDL) prescribed, out of total number of drugs prescribed

PR10: Number of drugs from the national essential drugs list (EDL) sold, out of total number of drugs sold

PR11: Number of locally manufactured drugs sold in the country from the national essential drugs list (EDL), out of number of drugs from the national essential drugs list (EDL)

PR12: Number of combination drugs newly registered, out of total number of newly registered drugs

PR13: Number of registered drugs which are banned in other countries, out of total number of registered drugs

Drug allocation in the health budget/public sector financing policy

PR14: Value of public drug budget spent per capita in the last year, out of average value of the same budget during the past three years

PR15: Value of public drug budget spent by major hospitals, out of value of public drug budget spent

1
PR16: Value of international aid received for drugs, out of value of public drug budget

PR17: Value of revenue generated for drugs through additional financing systems, out of value of public drug budget

PR18: Public drug budget spent, out of public drug budget allocated

Public sector procurement procedures

PR19: Value of drugs purchased through competitive tender, out of value of drugs purchased

PR20: Value of drugs purchased from local manufacturers through competitive tender, out of value of drugs purchased through competitive tender

PR21: CIF/ex-factory value of a basket of drugs, out of CIF/ex-factory value of the same basket the year of reference

PR22: CIF/ex-factory value of a basket of drugs, out of "reference" value on the international market of the same basket

PR23: Average lead time for a sample of orders in the last year, out of average lead time during the past three years

PR24: Average time period of payment for a sample of orders, out of average time period of payment stated in contract

PR25: Number of drugs/batches tested, out of number of drugs/batches procured

PR26: Number of drugs/batches that failed quality control testing, out of number of drugs/batches tested

Public sector distribution and logistics

PR27: Average time between order and delivery from central store to remote facilities in the last year, out of average time between order and delivery in the past three years

PR28: Average stockout duration for a basket of drugs in the central and/or regional stores in the last year, out of average stockout duration for the same basket in the past three years

PR29: Average stockout duration for a basket of drugs in a sample of remote facilities in the last year, out of average stockout duration for the same basket in the past three years

Pricing policy

PR30: Value of a basket of drugs, out of CIF/ex-factory value of the same basket

PR31: Average expenditure per prescription, out of average expenditure per prescription in the past three years

PR32: Value of a basket of drugs, out of value of the same basket the year of reference

Information and continuing education on drug use

PR33: Number of prescribers having direct access to a (national) drug formulary, out of total number of prescribers surveyed

PR34: Number of training sessions on drug use for prescribers in the last year, out of average number of training sessions organized in the past three years

PR35: Number of prescribers who have attended at least one training session in the last year, out of total number of prescribers surveyed

PR36: Number of issues of independent drug bulletins published in the last year, out of average number of issues of independent drug bulletins published per year in the past three years

PR37: Average number of copies of independent drug bulletins sent to prescribers, out of total number of prescribers

PR38: Amount spent on public education campaigns on drug use, out of total amount spent on public health education campaigns